Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism
Identifieur interne : 003F05 ( Main/Exploration ); précédent : 003F04; suivant : 003F06Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism
Auteurs : Amy N. Hill [États-Unis] ; Joseph Jankovic [États-Unis] ; Kevin D. A. T. Vuong [États-Unis] ; Don Donovan [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2003-10.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Adulte.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Collagen, Collagen (therapeutic use), Complication, Drug Administration Schedule, Female, Functional aphonia, Humans, Injection, Instrumentation therapy, Male, Parkinson disease, Parkinsonian Disorders (complications), Parkinsonian Disorders (physiopathology), Parkinsonism, Patient Satisfaction, Prognosis, Questionnaires, Time Factors, Treatment Outcome, Vocal Cords (drug effects), Vocal cord, Voice Disorders (drug therapy), Voice Disorders (etiology), Voice Disorders (physiopathology), Voice Quality.
- MESH :
- chemical , therapeutic use : Collagen.
- complications : Parkinsonian Disorders.
- drug effects : Vocal Cords.
- drug therapy : Voice Disorders.
- etiology : Voice Disorders.
- physiopathology : Parkinsonian Disorders, Voice Disorders.
- Aged, Aged, 80 and over, Drug Administration Schedule, Female, Humans, Male, Patient Satisfaction, Questionnaires, Time Factors, Treatment Outcome, Voice Quality.
Abstract
We conducted structured interviews of patients with Parkinson's disease (PD) and other parkinsonian disorders and their caregivers after augmentation of vocal folds with collagen injections. A total of 12 patients (mean age, 73.7 ± 8.6 years) completed the questionnaire after an average of 3.0 ± 1.7 collagen injections, with an average of 13.8 ± 7.4 weeks between each injection. In addition to improvement in all six voice quality questions, there was significant improvement (P < 0.05) in the Glascow Benefit Inventory (GBI) score. The injection procedure was tolerated well by patients with an average duration of benefit lasting 7.8 ± 8.5 weeks. Augmentation of vocal folds with collagen provides temporary improvement in voice in patients with parkinsonian hypophonia. © 2003 Movement Disorder Society
Url:
DOI: 10.1002/mds.10554
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001190
- to stream Istex, to step Curation: 001190
- to stream Istex, to step Checkpoint: 002834
- to stream PubMed, to step Corpus: 003660
- to stream PubMed, to step Curation: 003660
- to stream PubMed, to step Checkpoint: 003601
- to stream Ncbi, to step Merge: 000C04
- to stream Ncbi, to step Curation: 000C04
- to stream Ncbi, to step Checkpoint: 000C04
- to stream Main, to step Merge: 005B27
- to stream PascalFrancis, to step Corpus: 002371
- to stream PascalFrancis, to step Curation: 000950
- to stream PascalFrancis, to step Checkpoint: 002288
- to stream Main, to step Merge: 005E34
- to stream Main, to step Curation: 003F05
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism</title>
<author><name sortKey="Hill, Amy N" sort="Hill, Amy N" uniqKey="Hill A" first="Amy N." last="Hill">Amy N. Hill</name>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
<author><name sortKey="Vuong, Kevin D A T" sort="Vuong, Kevin D A T" uniqKey="Vuong K" first="Kevin D. A. T." last="Vuong">Kevin D. A. T. Vuong</name>
</author>
<author><name sortKey="Donovan, Don" sort="Donovan, Don" uniqKey="Donovan D" first="Don" last="Donovan">Don Donovan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A975E9317C66C099394A3D68A8446D6E85D1B142</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/mds.10554</idno>
<idno type="url">https://api.istex.fr/document/A975E9317C66C099394A3D68A8446D6E85D1B142/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001190</idno>
<idno type="wicri:Area/Istex/Curation">001190</idno>
<idno type="wicri:Area/Istex/Checkpoint">002834</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Hill A:treatment:of:hypophonia</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:14534926</idno>
<idno type="wicri:Area/PubMed/Corpus">003660</idno>
<idno type="wicri:Area/PubMed/Curation">003660</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003601</idno>
<idno type="wicri:Area/Ncbi/Merge">000C04</idno>
<idno type="wicri:Area/Ncbi/Curation">000C04</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000C04</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Hill A:treatment:of:hypophonia</idno>
<idno type="wicri:Area/Main/Merge">005B27</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0095340</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002371</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000950</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002288</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Hill A:treatment:of:hypophonia</idno>
<idno type="wicri:Area/Main/Merge">005E34</idno>
<idno type="wicri:Area/Main/Curation">003F05</idno>
<idno type="wicri:Area/Main/Exploration">003F05</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism</title>
<author><name sortKey="Hill, Amy N" sort="Hill, Amy N" uniqKey="Hill A" first="Amy N." last="Hill">Amy N. Hill</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
<author><name sortKey="Vuong, Kevin D A T" sort="Vuong, Kevin D A T" uniqKey="Vuong K" first="Kevin D. A. T." last="Vuong">Kevin D. A. T. Vuong</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Donovan, Don" sort="Donovan, Don" uniqKey="Donovan D" first="Don" last="Donovan">Don Donovan</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Otorhinolaryngology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2003-10">2003-10</date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">10</biblScope>
<biblScope unit="page" from="1190">1190</biblScope>
<biblScope unit="page" to="1192">1192</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">A975E9317C66C099394A3D68A8446D6E85D1B142</idno>
<idno type="DOI">10.1002/mds.10554</idno>
<idno type="ArticleID">MDS10554</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Collagen</term>
<term>Collagen (therapeutic use)</term>
<term>Complication</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Functional aphonia</term>
<term>Humans</term>
<term>Injection</term>
<term>Instrumentation therapy</term>
<term>Male</term>
<term>Parkinson disease</term>
<term>Parkinsonian Disorders (complications)</term>
<term>Parkinsonian Disorders (physiopathology)</term>
<term>Parkinsonism</term>
<term>Patient Satisfaction</term>
<term>Prognosis</term>
<term>Questionnaires</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Vocal Cords (drug effects)</term>
<term>Vocal cord</term>
<term>Voice Disorders (drug therapy)</term>
<term>Voice Disorders (etiology)</term>
<term>Voice Disorders (physiopathology)</term>
<term>Voice Quality</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Collagen</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Vocal Cords</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Voice Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Voice Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinsonian Disorders</term>
<term>Voice Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Patient Satisfaction</term>
<term>Questionnaires</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Voice Quality</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Adulte</term>
<term>Aphonie fonctionnelle</term>
<term>Collagène</term>
<term>Complication</term>
<term>Corde vocale</term>
<term>Hypophonie</term>
<term>Injection</term>
<term>Parkinson maladie</term>
<term>Parkinsonisme</term>
<term>Pronostic</term>
<term>Traitement instrumental</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We conducted structured interviews of patients with Parkinson's disease (PD) and other parkinsonian disorders and their caregivers after augmentation of vocal folds with collagen injections. A total of 12 patients (mean age, 73.7 ± 8.6 years) completed the questionnaire after an average of 3.0 ± 1.7 collagen injections, with an average of 13.8 ± 7.4 weeks between each injection. In addition to improvement in all six voice quality questions, there was significant improvement (P < 0.05) in the Glascow Benefit Inventory (GBI) score. The injection procedure was tolerated well by patients with an average duration of benefit lasting 7.8 ± 8.5 weeks. Augmentation of vocal folds with collagen provides temporary improvement in voice in patients with parkinsonian hypophonia. © 2003 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Texas</li>
</region>
<settlement><li>Houston</li>
</settlement>
<orgName><li>Baylor College of Medicine</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Texas"><name sortKey="Hill, Amy N" sort="Hill, Amy N" uniqKey="Hill A" first="Amy N." last="Hill">Amy N. Hill</name>
</region>
<name sortKey="Donovan, Don" sort="Donovan, Don" uniqKey="Donovan D" first="Don" last="Donovan">Don Donovan</name>
<name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<name sortKey="Vuong, Kevin D A T" sort="Vuong, Kevin D A T" uniqKey="Vuong K" first="Kevin D. A. T." last="Vuong">Kevin D. A. T. Vuong</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F05 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003F05 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:A975E9317C66C099394A3D68A8446D6E85D1B142 |texte= Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism }}
This area was generated with Dilib version V0.6.23. |